Related Experiment Video
Updated: Jun 5, 2026

07:42
Quantification of the Potential Impact of Glyphosate-Based Products on Microbiomes
Published on: January 10, 2022
A semi-quantitative approach to GMO risk-benefit analysis.
1African Centre for Gene Technologies, PO Box 75011, Lynnwood Ridge 0040, South Africa. ejanemorris@gmail.com
Transgenic Research
|January 4, 2011
Summary
This study introduces a simple risk-benefit analysis methodology for genetically modified organisms (GMOs). It aids regulators, especially in developing nations, in evaluating GMO benefits alongside risks for better decision-making.
Area of Science:
- Agricultural Biotechnology
- Environmental Science
- Regulatory Science
Background:
- Growing global demand for considering both risks and benefits of genetically modified organisms (GMOs).
- Current regulatory frameworks, influenced by the Precautionary Principle, often focus primarily on risks.
- Lack of well-defined methodologies for conducting GMO risk-benefit analyses hinders regulatory processes.
Purpose of the Study:
- To present a straightforward, semi-quantitative methodology for GMO risk-benefit analysis.
- To provide a decision-support tool for regulators, particularly in resource-limited settings.
- To facilitate the integration of risk-benefit analysis into GMO regulatory frameworks.
Main Methods:
- Development of a semi-quantitative risk-benefit analysis framework.
- Application of the methodology to a case study involving insect-resistant maize in South Africa.
- Evaluation of the methodology's applicability within an existing regulatory system.
Main Results:
- Demonstrated a practical approach for assessing GMOs considering both risks and benefits.
- The methodology is adaptable for regulators in developing countries with limited resources.
- Case study illustrated the process and potential integration into regulatory systems.
Conclusions:
- A defined methodology can support the shift towards risk-benefit analysis in GMO regulation.
- The proposed tool is accessible and useful for regulators, especially in developing nations.
- Adapting regulatory processes to include risk-benefit analysis is feasible and beneficial.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
What is Genetic Engineering?
Overview

